Cancer pain, fatigue, distress, and insomnia in cancer patients

Clinical Cornerstone

Volumn 6, Issue 1 SUPPL. 4, 2004, Pages

  Theobald, Dale E ^a  

^a Quality of Life Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; DESIPRAMINE; DEXAMETHASONE; DOXEPIN; FLUOXETINE; GRANISETRON; HYDROCORTISONE; HYPNOTIC AGENT; METHYLPHENIDATE; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; PREDNISONE; PROCHLORPERAZINE; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZALEPLON; ZOLPIDEM;

ADVANCED CANCER; ANOREXIA; ANXIETY DISORDER; ARTICLE; AWARENESS; BEHAVIOR THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COGNITIVE THERAPY; CONSTIPATION; DELIRIUM; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISTRESS SYNDROME; DIZZINESS; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FATIGUE; HEADACHE; HEALTH STATUS; HUMAN; HYDROCORTISONE RELEASE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INSOMNIA; MENTAL DISEASE; NAUSEA; NAUSEA AND VOMITING; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; SEDATION; SLEEP DISORDER; SOMNOLENCE; SYMPTOMATOLOGY; TACHYCARDIA; TREATMENT PLANNING; TREMOR; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; INTRACTABLE PAIN; MALE; MULTIMODALITY CANCER THERAPY; NEOPLASM; REVIEW; RISK ASSESSMENT;

COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSION; FATIGUE; FEMALE; HUMANS; MALE; NEOPLASMS; PAIN, INTRACTABLE; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 14544301908     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(05)80003-1     Document Type: Article

References (19)

1. Savard J Morin CM Insomnia in the context of cancer: A review of a neglected problem J Clin Oncol 19 2001 895-908
2. Portenoy RK Thaler HT Kornblith AB et al. Symptom prevalence, characteristics and distress in a cancer population Qual Life Res 3 1994 183-189
3. Anderson KO Getto CJ Mendoza TR et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults J Pain Symptom Manage 25 2003 307-318
4. Davidson JR MacLean AW Brundage MD Schulze K Sleep disturbance in cancer patients Soc Sci Med 54 2002 1309-1321
5. Vgontzas AN Chrousos GP Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders Endocrinol Metab Clin North Am 31 2002 15-36
6. Irwin M Clark C Kennedy B et al. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects Brain Behav Immun 17 2003 365-372
7. Available at National Comprehensive Cancer Network Clinical Practice Guidelines. Cancer-Related Fatigue, version 1.2004 http://www.nccn.org./professionals/physician_gls/PDF/fatigue.pdf
8. Grond S Zech D Diefenbach C et al. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic J Pain Symptom Manage 9 1994 372-382
9. Smith MT Haythornthwaite JA How do sleep disturbance and chronic pain interrelate? Insights from the longitudinal and cognitive-behavioral clinical trials literature Sleep Med Rev 8 2004 119-132
10. Portenoy RK Itri LM Cancer-related fatigue: Guidelines for evaluation and management The Oncologist 4 1999 1-10
11. Chrousos GA Kattah JC Beck RW Cleary PA Side effects of glucocorticoid treatment JAMA 269 1993 2110-2112
12. Ford DB Kamerow DB Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 262 1989 1479-1484
13. Spiegel D Sephton SE Psychoneuroimmune and endocrine pathways in cancer: Effects of stress and support Semin Clin Neuropsychiatry 6 2001 252-265
14. Sephton SE Sapolsky RM Kraemer HC Spiegel D Diurnal cortisol rhythm as a predictor of breast cancer survival J Natl Cancer Inst 92 2000 994-1000
15. Fortner BV Stepanski EJ Wang SC et al. Sleep and quality of life in breast cancer patients J Pain Symptom Manage 24 2002 471-480
16. Available at National Cancer Institute Sleep Disorder (PDQ®) Health Professional Version 2002 US National Institutes of Health Washington, DC http://www.cancer.gov/cancertopics/pdq/supportivecare/sleepdisorders.
17. Neubauer DN Pharmacologic approaches for the treatment of chronic insomnia Clin Cornerstone 5 2003 16-27
18. Mendelson WB Roth T Cassella J et al. The treatment of chronic insomnia: Drug indications, chronic use and abuse liability Summary of a 2001 New Clinical Drug Evaluation Unit Meeting Symposium Sleep Med Rev 8 2004 7-17
19. 19. Lee K Cho M Miaskowski C Dodd M Impaired sleep and rhythms in persons with cancer Sleep Med Rev 8 2004 199-212